CMS Meets With Hospice Stakeholders On Controversial Drug Guidance

CMS met Wednesday (June 25) with 30 stakeholder groups to discuss controversial drug prior-authorization guidelines for hospice beneficiaries, and a bipartisan majority in both chambers of Congress recently signed letters asking CMS to put the drug prior-authorization guidance on hold. Stakeholders have raised concerns that the guidance requires patients to navigate payment disputes between Part D plans and hospices, which is an undue burden on dying beneficiaries and their caregivers. Senate Majority Leader Harry Reid (D-NV) wrote CMS just prior...